Type : Contract
HPV TEST KITS Solicitation ID/Procurement Identifier: 36C24420A0002 Ultimate Completion Date: Mon Sep 30 17:00:00 GMT 2024
HPV TEST KITS Solicitation ID/Procurement Identifier: 36C24420A0002 Ultimate Completion Date: Mon Sep 30 17:00:00 GMT 2024
Respondents are encouraged to provide their product catalog.Responding Business Identification InformationFirm Name and Physical Address:CAGE Code: Contact for Firm: Name, Title, Phone Number, and E-mail Address: Business Size: Product Information:What types of HPV kits does your company provide and what equipment (if any) is required to process the results of the test kits?
Base Plus 4 Option Year FSS-BPA Base Year POP: 10/01/2019 - 09/30/2020 $87,839.10 Option Year 1: 10/01/2020 - 09/30/2021 $87,839.10 Option Year 2: 10/01/2021 - 09/30/2022 $87,839.10 Option Year 3: 10/01/2022 - 09/30/2023 $87,839.10 Option Year 4: 10/01/2023 - 09/30/2024 $87,839.10 Total Estimated Contract Value $439,195.50 An FSS-BPA-DO has been awarded to execute the Base Year in the amount of $87,839.10
Contract SPE2DE-19-D-0021
TASKS, DELIVERABLES/SUPPLIES Contractor shall provide the following deliverables annually during the contract: ITEM NUMBER DESCRIPTION QUANTITY Cobas 6800 system reagent rental 1 Classic service agreement 1 Basic or Advanced operator training slot 1 9343733190 Cobas SARS-CoV-2 Test kit (480 Tests) 41 7460066190 Cobas CT/NG test kit (480 Tests) IVD 52 7460155190 Cobas HPV Test kit (480 Test) IVD 22 6998798190 Cobas HCV Test kit (96 Tests) IVD 38 6998836190
Order to include the following reagents: P/N: PRD-03565: Aptima HIV-1 Quant, US IVD Kit (100 Tests) P/N: PRD-03705: Aptima HCV Quant Dx Assay Kit (100 Test) P/N: 303570: Aptima HPV Assay Kit (100 Test) P/N: 301154C Aptima Specimen Transfer Kit (LPT) (100 Test) P/N: 303010: Aptima HPV Calibrator Kit P/N: 303011: Aptima HPV Controls Kit P/N: 303236-CPR: Aptima HPV 16 18/45 Genotype Assy, Cost Per Reportable P/N: PRD-06419: SARS-CoV-2 Assay kit, EUA
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG) has a need for five thousand two hundred (5200) Human Papillomavirus (HPV) genotyping test kits, two (2) polymerase chain reaction (PCR) systems, and eight hundred (800) cervical specimen collection kits.